Top

Supportive Care in Cancer

Published in:

Open Access 01-09-2017 | Original Article

Voice rehabilitation after laryngeal cancer: Associated effects on psychological well-being

Authors: Liza Bergström, Elizabeth C Ward, Caterina Finizia

Published in: Supportive Care in Cancer | Issue 9/2017

Abstract

Purpose

Psychological distress after laryngeal cancer treatment is prevalent. Although voice rehabilitation has shown to improve functional outcomes and positively affect health-related quality of life, to date, there has been limited study of the associated effect of behavioural voice intervention on psychological well-being/distress post laryngeal cancer.

Method

Sixty-three patients with Tis-T4 laryngeal cancer treated with (chemo)radiotherapy were prospectively recruited and randomised to either a voice rehabilitation (VR, n = 31) or control group (n = 32). The VR group received 10 speech pathology sessions consisting of both direct and indirect voice intervention post (chemo)radiotherapy. The control group received general voice education but not specific intervention. As part of a multidisciplinary assessment battery, psychological well-being/distress was measured using the Hospital Anxiety and Depression Scale (HADS) pre, six and 12 months post VR.

Results

Within-group analysis revealed a significant (p = 0.03) reduction in the proportion of patients with anxiety in the VR group between baseline and 12 months. No change over time was observed in controls. Between-group analysis revealed a trend for fewer VR cases demonstrating anxiety (p = 0.06) or depression (p = 0.08) at 6 months and significantly fewer demonstrating anxiety (p = 0.04) and depression (p = 0.04) at 12 months, compared to controls. Significant correlations were observed between patients’ voice perceptions and reduced anxiety (r _pb = −0.38) and depression (r _pb = −0.66) within the VR group at 12 months.

Conclusions

The positive correlations and between-group analyses indicate a positive effect on psychological well-being associated with completing voice rehabilitation. Results highlight potential additional benefits of behavioural voice intervention beyond achieving direct change to voice function.

Karlsson T, Bergström L, Ward E, Finizia C (2016) A prospective longitudinal study of voice characteristics and health-related quality of life outcomes following laryngeal cancer treatment with radiotherapy. Acta Oncol 55(6):693–699. doi:10.3109/0284186X.2016.1150604 CrossRefPubMed

Morgan DAL, Robinson HF, Marsh L, Bradley PJ (1988) Vocal quality 10 years after radiotherapy for early glottic cancer. Clin Radiol 39(3):295–296. doi:10.1016/S00099260(88)805415 CrossRefPubMed

Bibby JR, Cotton SM, Perry A, Corry JF (2008) Voice outcomes after radiotherapy treatment for early glottic cancer: assessment using multidimensional tools. Head & neck 30(5):600–610. doi:10.1002/hed.20750 CrossRef

van der Molen L, van Rossum MA, Jacobi I, van Son RJ, Smeele LE, Rasch CR, Hilgers FJ (2012) Pre- and posttreatment voice and speech outcomes in patients with advanced head and neck cancer treated with chemoradiotherapy: expert listeners’ and patients perception. J Voice 26(5):e625–e633. doi:10.1016/j.jvoice.2011.08.016

Meleca RJ, Dworkin JP, Kewson DT, Stachler RJ, Hill SL (2003) Functional outcomes following nonsurgical treatment for advanced-stage laryngeal carcinoma. Laryngoscope 113(4):720–728. doi:10.1097/00005537-200304000-00025 CrossRefPubMed

Peeters AJGE, van Gogh CDL, Goor K, Verdonck-de Leeuw IM, Langendijk JA, Mahieu HF (2004) Health status and voice outcome after treatment for T1a glottic carcinoma. European Archives of Oto-Rhino-Laryngology and Head & Neck 261(10):534–540. doi:10.1007/s00405-003-0697-5 CrossRef

Szuecs M, Kuhnt T, Punke C, Witt G, Klautke G, Kramp B, Hildebrandt G (2015) Subjective voice quality, communicative ability and swallowing after definitive radio (chemo)therapy, laryngectomy plus radio (chemo)therapy, or organ conservation surgery plus radio (chemo) therapy for laryngeal and hypopharyngeal cancer. J Radiat Res. doi:10.1093/jrr/rru093 PubMed

Hocevar-Boltezar I, Zargi M, Strojan P (2009) Risk factors for voice quality after radiotherapy for early glottic cancer. Radiother Oncol 93(3):524–529. doi:10.1016/j.radonc.2009.09.014 CrossRefPubMed

Bergström L, Ward EC, Finizia C (2016) Voice rehabilitation for laryngeal cancer patients: functional outcomes and patient perceptions. The Laryngoscope:n/a-n/a. doi:10.1002/lary.25919

10.

Johansson M, Ryden A, Finizia C (2008) Self evaluation of communication experiences after laryngeal cancer—a longitudinal questionnaire study in patients with laryngeal cancer. BMC Cancer 8:80. doi:10.1186/1471-2407-8-80 CrossRefPubMedPubMedCentral

11.

Nordgren M, Abendstein H, Jannert M, Boysen M, Ahlner-Elmqvist M, Silander E, Bjordal K, Hammerlid E (2003) Health-related quality of life five years after diagnosis of laryngeal carcinoma. International Journal of Radiation Oncology Biology Physics 56 (5):1333-1343:10.1016/S0360-3016(03)00292-X

12.

Siupsinskiene N, Vaitkus S, Grebliauskaite M, Engelmanaite L, Sumskiene J (2008) Quality of life and voice in patients treated for early laryngeal cancer. Medicina Kaunas, Lithuania 44(4):288–295PubMed

13.

Hammerlid E, Mercke C, Sullivan M, Westin T (1998) A prospective quality of life study of patients with laryngeal carcinoma by tumor stage and different radiation therapy schedules. Laryngoscope 108(5):747–759CrossRefPubMed

14.

Singer S, Danker H, Dietz A, Hornemann B, Koscielny S, Oeken J, Matthaus C, Vogel H, Krauss O (2008) Screening for mental disorders in laryngeal cancer patients: a comparison of 6 methods. Psychooncology 17(3):280–286CrossRefPubMed

15.

Johansson M, Ryden A, Finizia C (2011) Mental adjustment to cancer and its relation to anxiety, depression, HRQL and survival in patients with laryngeal cancer. A longitudinal study. BMC Cancer 11(1):283CrossRefPubMedPubMedCentral

16.

van Gogh CD, Verdonck-de Leeuw IM, Boon-Kamma BA, Rinkel RN, de Bruin MD, Langendijk JA, Kuik DJ, Mahieu HF (2006) The efficacy of voice therapy in patients after treatment for early glottic carcinoma. Cancer 106(1):95–105. doi:10.1002/cncr.21578 CrossRefPubMed

17.

van Gogh CDL, Verdonck-de Leeuw IM, Langendijk JA, Kuik DJ, Mahieu HF (2012) Long-term efficacy of voice therapy in patients with voice problems after treatment of early glottic cancer. J Voice 26(3):398–401. doi:10.1016/j.jvoice.2011.06.002 CrossRefPubMed

18.

Tuomi L, Andréll P, Finizia C (2014) Effects of voice rehabilitation after radiation therapy for laryngeal cancer: a randomized controlled study. International Journal of Radiation Oncology Biology Physics 89(5):964–972. doi:10.1016/j.ijrobp.2014.04.030 CrossRef

19.

Karlsson T, Johansson M, Andréll P, Finizia C (2015) Effects of voice rehabilitation on health-related quality of life, communication and voice in laryngeal cancer patients treated with radiotherapy: a randomised controlled trial. Acta Oncol 54(7):110171024. doi:10.3109/0284186X.2014.995773 CrossRef

20.

Rinkel RNPM, Verdonck-de Leeuw IM, van den Brakel N, de Bree R, Eerenstein SEJ, Aaronson N, Leemans CR (2014) Patient-reported symptom questionnaires in laryngeal cancer: voice, speech and swallowing. Oral Oncol 50(8):759–764. doi:10.1016/j.oraloncology.2014.05.009 CrossRefPubMed

21.

Pocock SJ, Simon R (1975) Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31(1):103–115. doi:10.2307/2529712 CrossRefPubMed

22.

Zigmond A, Snaith R (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361–370CrossRefPubMed

23.

Stern AF (2014) The Hospital Anxiety and Depression Scale. Occup Med 64(5):393–394. doi:10.1093/occmed/kqu024 CrossRef

24.

Finizia C, Hammerlid E, Westin T, Lindström J (1998) Quality of life and voice in patients with laryngeal carcinoma, a posttreatment comparison of laryngectomy (salvage surgery) versus radiotherapy. Laryngoscope 108(10):1566–1573. doi:10.1097/00005537-199810000-00027 CrossRefPubMed

25.

Finizia C, Lindström J, Dotevall H (1998) Intelligibility and perceptual ratings after treatment for laryngeal cancer: laryngectomy versus radiotherapy. Laryngoscope 108(1):138–143. doi:10.1097/00005537-199801000-00027 CrossRefPubMed

26.

Lowry R (2016) VassarStats: Website for Stastical Computation. Retrieved from http://vassarstats.Net/pbcorr.Html. Accessed 8 august, 2016.

27.

Hinkle D, Wiersma W, Jurs S (2003) Applied statistics for the behavioral sciences. Houghton Mifflin, Boston, Massachusetts

28.

Ringash J (2015) Survivorship and quality of life in head and neck cancer. J Clin Oncol 33(29):3322–3327. doi:10.1200/jco.2015.61.4115 CrossRefPubMed

29.

Aarstad HJ, Osthus AA, Olofsson J, Aarstad AKH (2014) Level of distress predicts subsequent survival in successfully treated head and neck cancer patients a prospective cohort study. Acta Otolaryngol 134(2):211–219. doi:10.3109/00016489.2013.841989 CrossRefPubMed

30.

Howren MB, Christensen AJ, Karnell LH, Funk GF (2013) Psychological factors associated with head and neck cancer treatment and survivorship, evidence and opportunities for behavioral medicine. J Consult Clin Psychol 81(2):299–317. doi:10.1002/hed.10174 CrossRefPubMed

31.

McEwen SE, Davis AM, Jones JM, Martino R, Poon I, Rodriguez AM, Ringash J (2015) Development and preliminary evaluation of a rehabilitation consult for survivors of head and neck cancer: an intervention mapping protocol. Implement Sci 10(1):1–9. doi:10.1186/s13012-014-0191-z CrossRef

32.

Turner J, Yates P, Kenny L, Gordon LG, Burmeister B, Thomson D, Hughes B, McCarthy AL, Perry C, Chan RJ, Fraser A, Skerman H, Batstone M, Carswell K (2014) The ENHANCES study—enhancing head and neck cancer patients experiences of survivorship: study protocol for a randomized controlled trial. Trials 15(1):1–9. doi:10.1186/1745-6215-15-191 CrossRef

33.

van der Meulen IC, May AM, de Leeuw JRJ, Koole R, Oosterom M, Hordijk GJ, Ros WJG (2014) Long-term effect of a nurse-led psychosocial intervention on health-related quality of life in patients with head and neck cancer a randomised controlled trial. Br J Cancer 110(3):593–601. doi:10.1038/bjc.2013.733 CrossRefPubMed

34.

Statistikdatabas för. cancer (2014) Socialstyrelsen, Stockholm. http://www.socialstyrelsen.se/statistik/statistikdatabas/cancer. Accessed 20 September, 2016

35.

Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr (2004) Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291(20):2441–2447. doi:10.1001/jama.291.20.2441 CrossRefPubMed

Title: Voice rehabilitation after laryngeal cancer: Associated effects on psychological well-being
Authors: Liza Bergström
Elizabeth C Ward
Caterina Finizia
Publication date: 01-09-2017
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 9/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-017-3676-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Method

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2017

Hospitalizations, outcomes, and management costs of febrile neutropenia in patients from a managed care population

Impact of sleep disorders in cognitive function of thyroid cancer survivors

Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer

Cardiorespiratory fitness and muscle strength in pancreatic cancer patients

Benefits and risks of a percutaneous endoscopic gastrostomy (PEG) for decompression in patients with malignant gastrointestinal obstruction

The prognostic performance of adding patient-reported outcomes to the MASCC risk index to identify low-risk febrile neutropenia patients with solid tumors and lymphomas

Keynote webinar | Spotlight on antibody–drug conjugates in cancer